anmelden
FTSE All-Share
5.543,09
PKT
+1,85
PKT
+0,03
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.03.20 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 11.03.20 | Prudential buy | Goldman Sachs Group Inc. | |
| 11.03.20 | Prudential Neutral | JP Morgan Chase & Co. | |
| 11.03.20 | London Stock Exchange (LSE) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.03.20 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 11.03.20 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.03.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 10.03.20 | Unilever kaufen | Credit Suisse Group | |
| 10.03.20 | Unilever kaufen | Credit Suisse Group | |
| 10.03.20 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 10.03.20 | Prudential buy | UBS AG | |
| 10.03.20 | Vodafone Group buy | UBS AG | |
| 10.03.20 | BAT Outperform | Credit Suisse Group | |
| 10.03.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 10.03.20 | HSBC Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.03.20 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 10.03.20 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 09.03.20 | AstraZeneca Sell | UBS AG | |
| 09.03.20 | Prudential Neutral | JP Morgan Chase & Co. | |
| 09.03.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.03.20 | Prudential buy | UBS AG | |
| 09.03.20 | BP Outperform | Bernstein Research | |
| 09.03.20 | Barclays overweight | JP Morgan Chase & Co. | |
| 09.03.20 | Shell (ex Royal Dutch Shell) market-perform | Bernstein Research | |
| 09.03.20 | Shell (ex Royal Dutch Shell) market-perform | Bernstein Research | |
| 06.03.20 | Vodafone Group buy | UBS AG | |
| 06.03.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 05.03.20 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 05.03.20 | BAT Outperform | Bernstein Research | |
| 04.03.20 | Barclays overweight | JP Morgan Chase & Co. | |
| 04.03.20 | Lloyds Banking Group Neutral | JP Morgan Chase & Co. | |
| 04.03.20 | London Stock Exchange (LSE) Outperform | Credit Suisse Group | |
| 03.03.20 | Rio Tinto Neutral | UBS AG | |
| 03.03.20 | GSK Underweight | Morgan Stanley | |
| 03.03.20 | BAT Equal-Weight | Morgan Stanley | |
| 03.03.20 | BAT overweight | JP Morgan Chase & Co. | |
| 02.03.20 | HSBC Underweight | JP Morgan Chase & Co. | |
| 02.03.20 | London Stock Exchange (LSE) Hold | Deutsche Bank AG | |
| 02.03.20 | BAT buy | Deutsche Bank AG | |
| 02.03.20 | GSK buy | UBS AG |